Secondary hyperparathyroidism (SHPT) is a common complication in patients with chronic kidney disease. In SHPT, the biology of parathyroid cells changes significantly toward diffuse nodular hyperplasia. Currently, diagnosis of SHPT is based on intact parathyroid hormone serum levels and parameters of mineral metabolism. The morphologic diagnosis of SHPT relies on high-resolution ultrasonography with color Doppler imaging. This report describes a maintenance hemodialysis patient with severe SHPT treated using conventional therapy (phosphate binders and oral/intravenous vitamin D or analogues) and the subsequent addition of a calcimimetic. The role of color Doppler ultrasonography in the diagnosis, clinical follow-up, and assessment of therapeutic response of SHPT is discussed. This case suggests that the availability of calcimimetics has changed the natural history of clinical SHPT and may change the therapeutic utility of parathyroidectomy. Use of color Doppler ultrasonography further supports these therapeutic advances, allowing evaluation of the morphologic and vascular changes in hyperplastic parathyroid glands and aiding clinical, pharmacologic, and surgical strategies. Am J Kidney Dis. 58(3):485-491.
INTRODUCTION
Secondary hyperparathyroidism (SHPT) is a serious complication of chronic kidney disease and maintenance hemodialysis (HD) therapy. Hypocalcemia, phosphate retention, and 1,25 dihydroxyvitamin D 3 deficiency are the stimuli behind the synthesis and release of parathyroid hormone (PTH).
1,2 Loss of renal mass results in persistent overstimulation of the parathyroid glands, resulting in changes to their cell biology, triggering cell hypertrophy-hyperplasia, and leading to the selection of cell clones with decreased calcium receptor and vitamin D receptor density. 1 Long-term hyperstimulation of the parathyroid glands produces glandular hyperplasia, which is at first polyclonal, then monoclonal and nodular, progressing to a growth disorder (tertiary hyperparathyroidism). 3 Nodular hyperplasia does not involve all glands or affect all patients with chronic kidney disease equally; therefore, it can be assumed that unknown genetic mechanisms may be involved. 4, 5 The identification of healthy parathyroid glands is difficult. However, high-resolution ultrasonography (US) with color Doppler imaging can be used to localize hyperplastic glands. Color Doppler US is the only technique that measures volumetric variations of the hyperplastic glands and provides semiquantitative parameters on glandular perfusion. 6 In this report, we describe a maintenance HD patient with severe SHPT treated using conventional therapy (phosphate binders and oral/intravenous vitamin D or analogues), then percutaneous ethanol injection, and finally the calcimimetic cinacalcet. We emphasize the role of color Doppler US to assess the response to therapy for SHPT.
CASE REPORT

Clinical History and Initial Laboratory Data
We present the case of a 51-year-old woman undergoing maintenance HD therapy since 1981 because of bladder exstrophy, urinary obstructive, and reflux uropathy with recurrent urinary tract infections. At 12 years of age, after multiple reconstructive surgeries, serum creatinine was 2.5 mg/dL [221 mol/L]). Cystography showed bilateral vesicoureteral reflux with grade IV hydronephrosis. A ureteral-sigmoidal-cutaneostomy was performed, but glomerular filtration rate progressively worsened. At the age of 22 years (serum creatinine, 12 mg/dL [1, 3 ) and an enlarged parathyroid gland (65 mm 3 ) was noted at the inferior pole of the left thyroid lobe.
In January 2005, color Doppler US showed 4 hyperplastic parathyroid glands. On the right side, the biggest gland was 22 ϫ 20 ϫ 21 mm with a volume of 4,827 mm 3 and appeared hypervascularized. The second gland was in the superior mediastinum on the right side and measured 9 ϫ 7 ϫ 5 mm with a volume of 164 mm 3 . On the left side, there were 2 parathyroid glands measuring 11 ϫ 8 ϫ 7 mm with a volume of 321 mm 3 (superior) and 9 ϫ 8 ϫ 7 mm with a volume of 263 mm 3 (inferior). Color Doppler showed a hypervascularized pattern.
In 2006, color Doppler US showed a small volume increase in the right inferior parathyroid gland due to cyst-like involutions and widespread hypovascularization. The decrease in volume of the other glands was not significant; however, intraglandular cyst-like areas were noted in the bigger glands.
In 2007, color Doppler US showed wide cystic degeneration of the largest gland, which appeared completely avascularized on color Doppler. A decrease in volume and structural alterations of the smaller gland (cystic areas and loss of color Doppler signal) became more evident. To evaluate the functional significance of the cyst-like involutions, technetium 99m ( 99m Tc) methoxyisobutyl isonitrile scintigraphy was performed. This showed an area of early and late hyperaccumulation of tracer near the inferior pole of the thyroid, but did not identify other glands.
In January 2010, color Doppler US showed that the right inferior gland was 22 ϫ 17 ϫ 20 mm with a volume of 3,979 mm 3 , and its morphologic and vascular patterns were unchanged. The mediastinal gland was hyperechoic and measured 6 ϫ 5 ϫ 3 mm with a volume of 47 mm 3 , the left superior gland was 9.9 ϫ 5.3 ϫ 4.2 mm with a volume of 214 mm 3 and absence of vascularization, and the left inferior gland was no longer distinguishable (Fig 1) .
Diagnosis
SHPT in a maintenance HD patient.
Clinical Follow-up
Laboratory data, imaging findings, and therapeutic interventions are listed in Table 1 . 
DISCUSSION
Color Doppler US of the parathyroid glands has a pivotal role in the diagnosis of SHPT, assessing the severity of disease and evaluating response to medical treatment. However, in clinical practice, color Doppler US is not commonly performed and SHPT diagnosis is based on iPTH serum levels and parameters of mineral metabolism.
Because parathyroid glands normally are heavily populated with adipose cells, they can be difficult to distinguish from thyroid parenchyma even with the use of high-resolution probes. 7 However, cellular hyperplasia makes the glands diffusely hypoechoic and easily detectable in the thyroid lodge. There is no set size threshold above which a parathyroid gland is identified as pathologic; however, if each of 2 diameters is Ͼ5 mm, a hypoechoic gland is judged hyperplastic 8 (Fig 2) . Glandular volume (in cubic millimeters) is calculated using the formula of an irregular ellipsoid (
The increase in glandular volume suggests increased PTH secretion and worsening of SHPT. 9 Studies that correlate glandular volume with histologic features of the excised glands at parathyroidectomy show that glands Ͻ500 mm 3 are affected mainly by diffuse and polyclonal hyperplasia, whereas glands Ͼ500 mm 3 are affected by monoclonal nodular hyperplasia in 80% of cases. Moreover, because there is wide variation in glandular volume, the overall sensitivity of color Doppler US in SHPT diagnosis is 74%-75% (Ͻ50% in the localization of parathyroids Ͻ500 mm 3 and Ͼ90% in glands Ն500 mm 3 ).
10
The ability to assess changes in glandular volume gives color Doppler US a unique advantage over SPECT (single-photon emission computed tomogra- 3 , aluminum hydroxide; ALP, alkaline phosphatase; Ca, calcium; Ca ϫ P, calcium-phosphorus product; CaCO 3 , calcium carbonate; iPTH, intact parathyroid hormone; IV, intravenous; LIG, left inferior parathyroid gland; LSG, left superior parathyroid gland; P, phosphorus; PEI, percutaneous ethanol injection; RIG, right inferior parathyroid gland; RMG, right mediastinic parathyroid gland; SHPT, secondary hyperparathyroidism; US, ultrasonography.
a Volume and (when applicable) vascular pattern assessed using color Doppler US. b No longer distinguishable.
phy)-scintigraphy, computed tomography, and magnetic resonance imaging. The increase in parathyroid gland volume is associated with a widespread increase in vascularity, evident histologically. [11] [12] [13] Usually color Doppler distinguishes 3 different patterns, 10 as shown in Fig 2D-F . According to international guidelines, SHPT diagnosis is based on iPTH serum levels and parameters of mineral metabolism. However, the optimal values for iPTH in maintenance HD patients are still uncertain, 14, 15 and hormone levels show great variability. 16 Because levels are influenced by drug therapy, iPTH level does not provide information for grading hyperplasia. Color Doppler US evaluates the degree of hyperplasia and number of glands involved, completing the biochemical diagnosis. We routinely perform color Doppler US of the parathyroid glands when iPTH values are consistently Ͼ400 pg/mL (Ͼ400 ng/L) and repeat this study annually in maintenance HD patients to evaluate the progression of disease. B-Mode parameters important for the assessment of SHPT progression include: (1) the gland's echogenicity, (2) gland diameter 17 and volume, (3) appearance of anechoic areas with no vascularization suggesting involutive cystic phenomena, and (4) presence of fibrocalcifications. 13 In our case, nodular hyperplasia of a single gland appeared after a long period of maintenance HD therapy. Color Doppler US was used to perform chemical ablation with percutaneous ethanol injection, but biochemical/morphologic results were poor. Afterward, other hyperplastic glands appeared, showing the slow but continuous progression of SHPT despite oral/intravenous vitamin D treatments. At this stage, the evidence of nodular hyperplasia on color Doppler US, severity of SHPT, and refractoriness to therapy with vitamin D/binders indicated the necessity of parathyroidectomy, which was refused by the patient.
The role of color Doppler US in the presurgical evaluation of SHPT is very different from primary hyperparathyroidism. The sensitivity of color Doppler US in the localization of adenoma/carcinoma is very high (90%-92%) for primary hyperparathyroidism, similar to that of conventional parathyroidectomy (93%-99%). 18 In a patient with SHPT, the role of imaging is less critical because parathyroidectomy is performed using conventional cervicotomy. Moreover, because there is wide variation in glandular volume and the overall sensitivity of color Doppler US for SHPT is lower than for primary hyperparathyroidism, the role of color Doppler US therefore should not be to localize the glands, but instead to determine surgical timing. Parathyroidectomy is indicated when color Doppler US evidences one or more hyperplastic glands Ն500 mm 3 , serum iPTH level is Ͼ700 pg/mL (Ͼ700 ng/L), and calcium, phosphorus, and calciumphosphorous product values are no longer controlled using conventional therapy. 19, 20 Glandular volume is related directly to the number of glands detected; it also may be highly variable and not entirely correlated with iPTH level at greater than a certain size/volume threshold. Calculated volume shows a linear correlation with iPTH value only when gland volume is Ͻ2,000 mm 3 (ie, Ͻ2 g). 8, 21 This observation suggests that the biggest glands tend to disengage from receptor control mechanisms (ie, upregulation of calcium receptor and vitamin D receptor) and grow independently.
In our patient, the combination of conventional therapy and cinacalcet marked a reversal in the progression of disease: PTH serum levels were decreased, mineral metabolism was stabilized, and color Doppler US showed progressive changes in volume and vascularization. The regression resembled a "chemical parathyroidectomy," and 5 years after beginning therapy, surgical parathyroidectomy was not necessary.
Color Doppler US showed a volume decrease associated with loss of vascular signal, progressing to complete disappearance of vascularization in the biggest glands (Ն500 mm 3 ; Fig 3) . Most glands involute (cystic-like lesions; Fig 4) , whereas glands Ͻ500 mm 3 show a volume decrease accompanied by a structural change toward hyperechogenicity, as if the relationship between cellularity and stromal adipose tissue had been reversed. This suggests that calcimimetic treatment modulates the biological response of cells with uncontrolled proliferation through direct stimulation of calcium receptor and vitamin D receptor expression. 18 In conclusion, if iPTH serum levels are constantly Ͼ400 pg/mL (Ͼ400 ng/L), color Doppler US can be performed to evaluate the presence of hyperplastic glands and complete the clinical diagnosis. This can be repeated once a year to evaluate disease progression. The availability of calcimimetics is changing the natural history of SHPT and may change the therapeutic utility of surgical parathyroidectomy. Use of color Doppler US further supports these therapeutic advances, allowing evaluation of morphologic and vascular changes in hyperplastic glands and aiding clinical, pharmacologic, and surgical strategies. 
